Almus Co-codamol 8/500 32 Tablets are a dependable option for individuals experiencing moderate discomfort, including headaches, dental pain, and muscular aches. The combination of paracetamol and codeine in each tablet makes Almus Co-codamol a compelling choice when common pain relievers like ibuprofen and aspirin fail to provide sufficient relief. Particularly useful for managing short-term pain, it allows users to carry on with their daily lives with significantly reduced discomfort. Suitable for adults and children over the age of 12, it stands as a preferred solution for quick and effective pain alleviation.

Key features

• Dual-action formula: Comprises 500mg of paracetamol and 8mg of codeine phosphate per tablet.
• Pain relief: Capable of addressing conditions such as migraines, toothaches, and rheumatic pains.
• Usage flexibility: Appropriate for both adults and children aged 12 and over.
• Short-term treatment: Geared towards the management of acute moderate pain.
• Easy to swallow: Tablets are crafted for straightforward oral intake.
• Regulated usage: Usage is advised for a maximum span of three days to avert the risk of dependency.

What symptoms or conditions can be treated with Almus Co-codamol?

Almus Co-codamol is utilized for the alleviation of acute moderate pain such as headaches, muscle pain, and dental pain.

What are the benefits of using Almus Co-codamol?

Almus Co-codamol delivers effective pain relief when other medications such as paracetamol or ibuprofen alone fall short.

How does Almus Co-codamol work?

The paracetamol and codeine blend operates by diminishing the intensity of pain signals sent to the brain and altering the perception of pain.

Are there any known side effects?

While some may experience dizziness, drowsiness, nausea, and constipation, serious side effects are uncommon but necessitate immediate medical attention.

Is Almus Co-codamol vegan?

Almus Co-codamol is not vegan as it contains lactose.

Can I take Almus Co-codamol if I am pregnant or breastfeeding?

Almus Co-codamol is not recommended during pregnancy or lactation without consulting a healthcare professional.

Main ingredients: 500mg paracetamol and 8mg codeine phosphate.

It may contain lactulose.

Please read the information leaflet provided for the full list of ingredients.

Always read the label.

Adults and children aged 16 to 18 years: One to two tablets every 6 hours when necessary up to a maximum of 8 tablets in 24 hours.

Children aged 12 to 15 years: One tablet every six hours when necessary to a maximum of four tablets in 24 hours.

• Paediatric population: Not recommended for children under 12 years of age.
• Sensitive patients: Exercise care when administering to elderly, those with prostatic hypertrophy, hypothyroidism, inflammatory or obstructive bowel disorders, Addison's disease, myasthenia gravis, or those on CNS depressants.
• Paracetamol caution: Use cautiously in severe renal or hepatic impairment. Overdose risk is higher in non-cirrhotic alcoholic liver disease.
• Flucloxacillin interaction: Increased risk of high anion gap metabolic acidosis (HAGMA) when taken with paraceatamol, especially in patients with severe renal impairment, sepsis, malnutrition, chronic alcoholism, or those taking maximum daily doses of paracetamol. Close monitoring recommended.
• Dosage advice: Do not exceed the recommended dose. Avoid taking with other paracetamol-containing products. Seek immediate medical advice in case of overdose.
• Convulsive disorders: Use with caution in patients with convulsive disorders.
• Addiction risk: This medicine can cause addiction if taken for more than 3 days. Withdrawal symptoms can occur if stopped abruptly.

• CYP2D6 metabolism: Codeine is metabolized to morphine by CYP2D6. Variations in metabolism can lead to insufficient analgesia or increased risk of toxicity.
• Post-operative use in children: Reports of life-threatening events in ultra-rapid or extensive metabolizers after tonsillectomy/adenoidectomy.
• Children with compromised respiratory function: Not recommended for use in children with conditions that may worsen respiratory function.
• Sedative medicines risk: Concomitant use with sedatives like benzodiazepines can cause sedation, respiratory depression, coma, and death. Use the lowest effective dose and shortest duration possible. Monitor closely for respiratory depression and sedation.
• Alcohol interaction: Concomitant use with alcohol can cause sedation, respiratory depression, coma, and death. Not recommended to use with alcohol.
• Medical advice for use: Use under medical advice for patients with mild-to-moderate hepatocellular insufficiency or severe renal insufficiency. Monitor blood count, liver function, and renal function after prolonged use.

Contraindications:

• Hypersensitivity to the active substances or any of the other excipients.

• In all paediatric patients (0-18 years of age) who undergo tonsillectomy and/or adenoidectomy for obstructive sleep apnoea syndrome due to an increased risk of developing serious and life-threatening adverse reactions

• In women during breastfeeding • In patients for whom it is known they are CYP2D6 ultra-rapid metabolisers

Codeine can produce typical opioid effects including constipation, nausea, vomiting, dizziness, light-headedness, confusion, drowsiness and urinary retention. The frequency and severity are determined by dosage, duration of treatment and individual sensitivity. Tolerance and dependence can occur, especially with prolonged high dosage of codeine.